Iron deficiency is the most common cause of anemia worldwide, yet desiderosmia remains rarely described as one of its manifestations. The term "desiderosmia" was first proposed in a case series by Hansen et al. to describe compulsive olfactory cravings for specific scents observed in three symptomatic patients with iron deficiency, derived from the Latin word "desiderare" for desire and the Greek word "osme" for smell. Desiderosmia appears to be closely related to pica, a common manifestation of iron deficiency, though the key difference is that patients report olfactory cravings without the desire to consume the scent-producing substance. As far as the authors of this report are aware, the number of published cases of desiderosmia is extremely scarce, and the term itself has yet to become recognized in medical literature, owing to its novelty. We report the case of a 32-year-old woman with menorrhagia and iron deficiency anemia (IDA) refractory to oral ferrous sulfate despite adherence. Despite her hemoglobin improving from 9.1 to 9.9 g/dL (reference range: 12-15.5 g/dL), her ferritin remained critically low at 1 ng/mL (reference range: 30-400 ng/mL). At that time, she developed an intense urge to smell pine-scented cleaning products, alongside migraines and restless leg syndrome, hypothesized to be neuropsychological symptoms linked to altered CNS iron homeostasis. We speculate that desiderosmia may share a similar neurological mechanism, correlating more closely with the severity of iron store depletion rather than with anemia severity. Recognition of this symptom prompted identification of IDA not improving with oral iron and escalation of therapy to IV ferrous carboxymaltose. Following treatment with intravenous iron repletion, her ferritin increased to 52 ng/mL, and she no longer experienced desiderosmia or any other iron deficiency symptoms. This case highlights the need for validating studies of desiderosmia's potential as a diagnostic marker in cases of severe iron deficiency and the symptom's pathophysiology.

In Japan, the microwave endometrial ablation system (MEA, Microsulis PLC, Waterlooville, UK) is the most widely used device for endometrial ablation and is considered a minimally invasive, uterus-preserving treatment for menorrhagia. Although MEA is generally safe, uterine and/or bowel perforation can occur as a rare but serious complication. We report a case of uterine and sigmoid colon perforations following hysteroscopy-guided MEA in a patient with a bicornuate uterus, endometriosis, and multiple uterine myomas. To our knowledge, this is the first reported case of simultaneous uterine and bowel perforation due to thermal injury after MEA in a patient with a bicornuate uterus. Careful preoperative evaluation and appropriate postoperative counseling are crucial, particularly in patients with uterine anomalies or suspected intra-abdominal adhesions.

Diffuse uterine leiomyomatosis is frequently misdiagnosed, highlighting the need to improve awareness and understanding of this rare condition. We report a case of a 29-year-old nulliparous woman presenting with menorrhagia who was diagnosed with diffuse uterine leiomyomatosis and underwent a two-stage hysteroscopic myomectomy. She subsequently conceived naturally and delivered a healthy full-term infant. In addition, we review the existing literature on diffuse uterine leiomyomatosis to enhance its diagnosis and management.

Uterine artery embolization is an established treatment for symptomatic fibroids, yet concerns persist regarding reproductive outcomes, particularly with intracavitary submucosal lesions. The current report describes the case of a 31-year-old woman who presented with severe menorrhagia and transfusion-dependent anemia. Investigations, including pelvic magnetic resonance imaging (MRI), demonstrated a large intracavitary submucosal fibroid completely occupying the endometrial cavity. She underwent an uncomplicated bilateral uterine artery embolization using polyvinyl alcohol particles, achieving near stasis on the left side and complete stasis on the right. Sixteen months later, she achieved spontaneous conception and experienced an uncomplicated antenatal course and healthy full-term delivery. No evidence of fibroid expulsion, infection, sepsis, or obstetric morbidity was observed. This case suggests that favorable reproductive and obstetric outcomes may be achievable after uterine artery embolization even for large intracavitary fibroids. It contributes to the growing evidence supporting uterine artery embolization as an alternative for women seeking fertility preservation in cases with similar characteristics.

Systemic lupus erythematosus (SLE) is a chronic, inflammatory, autoimmune disorder involving multiple systems. A 18-year-old female patient presented with complaints of headache, weakness, and tingling sensation in the left upper limb and lower limb. On magnetic resonance imaging (MRI), acute nonhemorrhagic infarct in right thalamo-capsular region was seen. The patient gave a history of malar rash and intermittent joint pains for which she had taken nonspecific treatment. Antineutrophilic antibody (ANA) by innumoflourescence and ANA blot was suggestive of SLE. Hence, the patient had central nervous system vasculitis and stroke due to SLE. The patient was started on antiplatelet therapy, tablet prednisolone 40 mg once daily, and tablet warfarin 5 mg once daily. The patient was readmitted after 2 weeks with menorrhagia and deranged INR. Tablet Warfarin was with-held, fresh frozen plasma transfusions were given. Repeat MRI did not show any new changes. Patient was given tablet nicoumalone and three doses of injection cyclophosphamide 800 mg. Hemiplegia has improved by 90%, her menstrual cycles are now regular.

We report an unusual case of a 46 year old diagnosed with follicular lymphoma within an ovarian teratoma. She sought medical attention due to menorrhagia, but was otherwise well. Positron Emission Tomography (PET) scanning demonstrated stage III disease, and she was treated with combination chemotherapy to complete metabolic remission on her end of treatment PET scan.